(Q43678213)

25 November 2017

title

Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? (English)

1 reference

25 November 2017

Cremers TI

1

1 reference

25 November 2017

Wiersma LJ

2

1 reference

25 November 2017

Bosker FJ

3

1 reference

25 November 2017

den Boer JA

4

1 reference

25 November 2017

Westerink BH

5

1 reference

25 November 2017

Wikström HV

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

published in

Biological Psychiatry

1 reference

25 November 2017

volume

50

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

13-21

1 reference

Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

5-HT and antidepressants: new views from microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Binding of?-adrenoceptor blocking drugs to human serum albumin, to ?1-acid glycoprotein and to human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Use of microdialysis to measure brain noradrenergic receptor function in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Stereoselective determination of plasma pindolol in endotoxin-pretreated rats by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Pindolol augmentation of antidepressant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

In vivo calibration of microdialysis probes for exogenous compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Metabolism of pindolol in patients with renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Chronic treatment with citalopram induces noradrenaline receptor hypoactivity. A microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Displacement of the binding of 5-HT1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

5-HT1A agonist activity of pindolol: reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Determination of adenosine and cyclic adenosine monophosphate in urine using solid-phase extraction and high-performance liquid chromatography with fluorimetric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901093-3

10.1016/S0006-3223(00)01093-3

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference